Ampio Pharmaceuticals, Inc.

Ampio Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their AMPE Losses Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Ampio Pharmaceuticals, Inc. (“Ampio”) (NYSE: AMPE). The class action is on behalf of shareholders who purchased or otherwise … Continue reading Ampio Pharmaceuticals, Inc.